Budget Impact of Niraparib As Maintenance Treatment for Medicare Patients with Recurrent Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer Who are in Complete or Partial Response to Platinum-Based Chemotherapy
May 1, 2018, 00:00 AM
10.1016/j.jval.2018.04.129
https://www.valueinhealthjournal.com/article/S1098-3015(18)30429-7/fulltext
Section Title :
Section Order :
671
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30429-7&doi=10.1016/j.jval.2018.04.129